U.K. Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Landscape

Category : Diagnostic and Biotech  | Published Date : Jul-2014 | Pages : 408

Complete report $1,850.  DataPack (test volumes, sales forecasts, supplier shares) $1,200.  The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget. 

This new study from Venture Planning Group contains 408 pages, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the next five years. 

Report Highlights

- Market shares of leading suppliers
- Business and technological trends in major markets
- Five-year test volume and sales forecasts
- Market shares of leading competitors
- Feature comparison of major analyzers
- Strategic profiles of leading market players and start-up firms developing innovative products
- Specific product and business opportunities for instrument and consumable suppliers.


Genetic Diseases, Cancer, Forensic and Paternity molecular diagnostic testing markets are among the most rapidly growing segments of the in vitro diagnostics industry.  The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches.  The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.  In order to successfully capitalize on the opportunities presented by these markets, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.  Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.

U.K. Market Overview

- Laboratories performing DNA sequencing and molecular diagnostic testing by country and market segment.

- Five-year test volume and sales projections.

Market Segmentation Analysis

- Five-year test volume and sales projections:

- Infectious Diseases        - Forensic Testing
- Cancer                            - Paternity Testing/HLA Typing
- Genetic Diseases            - Others

- A comprehensive analysis of the sequencing market by laboratory segment.
- Detailed market segmentation analysis, including review of the market dynamics, trends,
  structure, size, growth and major suppliers.

Product/Technology Review

- Comparison of the major molecular diagnostic analyzers.

- Extensive review of molecular diagnostic technologies, test formats, detection methodologies,
  trends in testing automation and over target/signal amplification methods.

- Worldwide listings of companies, universities and research centers developing new molecular
   diagnostic technologies and products.

Competitive Assessments

- Extensive strategic assessments of major suppliers and emerging market entrants,
  including their sales, product portfolios, marketing tactics, collaborative arrangements and
  new technologies/products in R&D.
   - Abbott
   - Affymetrix
   - Agilent Technologies
   - Applied Gene Technologies
   - Arca/Nuvelo
   - Beckman Coulter/Danaher
   - Becton Dickinson
   - Biokit
   - BioMerieux
   - Bio-Rad
   - Biotest
   - Caliper
   - Cepheid
   - Decode
   - Diadexus
   - Eiken
   - Enzo
   - Exact Sciences
   - Fujirebio/Innogenetics
   - Grifols
   - Hologic/Gen-Probe
   - Illumina
   - Kreatech
   - Li-Cor Biosciences
   - Life Technologies/Thermo Fisher
   - Monogram Biosciences
   - Myriad Genetics
   - Nanogen/Elitech
   - Orchid CellMark
   - Ortho-Clinical Diagnostics
   - Proteome Sciences
   - Qiagen              
   - Roche
   - Scienion
   - Sequenom
   - Shimadzu
   - Siemens
   - Sierra Molecular
   - Takara Bio
   - Tecan Group

- Comprehensive listings of companies developing and marketing molecular
  diagnostic products, by test and application.

Opportunities and Strategic Recommendations

- Specific new product development opportunities with potentially significant market appeal
  during the next five years.

- Design criteria for new products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

- Business planning issues and concerns.

Contains 408 pages

Please fill in the form below to download a TOC

* Marked Fields are Mandatory
Name * :
Email ID * :
Name of Company :
Phone No * :
Message :
Security code * :
Can't read the image? click here to refresh
Publisher Name :

Published Reports
Squalane is of a molecular formula C30H62 and has a specific stereochemical conformation. Squalane is traditionally sourced from shark liver or refined olive oil. It is highly sought after by formulators, due to its emollient properties. It is a high-end moisturizing ingredient used as an emollient in ....
US $3480
Notes: Production, means the output of Genome Editing/Genome Engineering Revenue, means the sales value of Genome Editing/Genome Engineering This report studies Genome Editing/Genome Engineering in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses ....
US $2900
Notes: Sales, means the sales volume of Atomic Fluorescence Spectrometer (AFS) Revenue, means the sales value of Atomic Fluorescence Spectrometer (AFS) This report studies sales (consumption) of Atomic Fluorescence Spectrometer (AFS) in Europe market, especially in Germany, UK, France, Russia, Italy, ....
US $3900

Upcoming Reports
Allergy is an exaggerated response of immune systems, which causes skin irritation, hay-fever, asthma, anaphylaxis and other symptoms. Therefore, it needs to be diagnosed and treated properly. In order to detect an allergy, skin tests and blood tests are performed by the healthcare providers .
US $ 4148
A clinical chemistry analyzer is use to analyze blood serum, plasma, urine and other body fluids with the help of various measurement technologies such as photometric and colorimetric testing, ion-selective potentiometry, and latex agglutination .
US $3390
Next Generation Sequencing (NGS) services, also known as high-throughput sequencing, is term used to describe sequencing technologies, such as Illumina sequencing, Roche 454 sequencing, and SOLiD sequencing .
US $3390
Please Select Format
Data Pack: US $ 1200
Local PDF: US $ 1850

market research offer
Contact us
Call us +1-971-202-1575
--- or ---
With high quality and penned to perfection, Big Market Research is an exclusive online market to get best market research reports for your business needs and strategies. We recommend you to stop browsing as soon as you discover our website. This is because we firmly believe that once you reach here; all your business concerns will be addressed.

We have a huge collection of market research report from numerous filed which will provide you with all the necessary solution. We make sure that reports that we sell are true in context, have a quality that is unrivaled, fully integrated with equal spread of opinion. They will give you proper insights into different opportunities one may locate for their start-up pr expansion.

Let your qualms and concern be sidelined through our high end syndicated as well as customized reports.